FDA Approves MORPHINE SULFATE — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. has received FDA approval for generic Morphine Sulfate Oral Solution, marking the company's strategic entry into the substantial market for this essential opioid analgesic. The approval is expected to drive revenue and capitalize on the increasing demand for accessible pain management therapies in the U.S. market.